1.
Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis;
凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响
2.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
3.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
4.
The Role of the Plasminogen Activator Inhibitor-1 in the Pathogenesis of Hepatic Fibrosis;
纤溶酶原激活物抑制剂-1在肝纤维化发生中的作用
5.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
6.
Cytokine-induced release of plasminogen activator inhibitor-1 by human pleural mesothelial cells
细胞因子诱导人胸膜细胞释放纤溶酶原激活物抑制剂-1的研究
7.
Research Progress of Plasminogen Activator Inhibitor One in Gestational Diabetes Mellitus
纤溶酶原激活物抑制剂-1（PAI-1）与妊娠期糖尿病的研究
8.
Effects of Tang Maiping on Plasminogen Activeator Inhibior in Blood Vessel of Type 2 Diabetic Rats
糖脉平对2型糖尿病大鼠血管纤溶酶原激活抑制剂表达的影响
9.
The Effect of Astragalus and Safflower Mixture on Expression of Plasminogen Activator Inhibitor 1 in Renal Tubulointerstitial Fibrosis in Rats with Unilateral Ureteral Obstruction;
芪红合剂对肾间质纤维化模型大鼠肾组织中纤溶酶原激活物抑制物-1表达的影响
10.
Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响
11.
A Case of Deficiency of Plasma Plasminogen Activator Inhibitor 1, Its Diagnosis, Treatment and Study on Molecular Abnormality
遗传性纤溶酶原激活剂抑制物-1缺乏症的诊断、治疗及发病机理的研究
12.
Regulation of Plasminogen Activator Inhibitor-1 Expression during 3T3-L1 Adipocytes Differentiation;
脂肪细胞分化过程中纤溶酶原激活剂抑制物-1基因的表达调控研究
13.
The Study on the Effect of Tissue-type Plasminogen Activator and Its Inhibitor-1 on the Formation of Pulmonary Thromboembolism;
组织型纤溶酶原激活物及其抑制剂-1对肺血栓栓塞症形成影响的探讨
14.
The Effect of Amiloride-an Inhibitor of Urokinase on the Pathology of Rat COPD Model;
尿激酶型纤溶酶原激活物抑制剂—氨氯吡咪对大鼠COPD模型病理改变的影响
15.
Role of Thrombomodulin and Plasminogen Activator Inhibitor-1 in Diabetic Retinopathy;
血栓调节蛋白和纤溶酶原激活物抑制剂-1在糖尿病视网膜病变中的作用
16.
Relationship between Sepsis and a 4G/5G Polymorphism Within the Promoter Region of Plasminogen Activator Inhibitor-1 (PAI-1) Gene;
纤溶酶原激活物抑制剂-1基因启动子区4G/5G多态性与脓毒症发生发展的相关性
17.
The Effects of CRP on the Expression of PGI_2、PAI-1 in ECV304 Cells;
C反应蛋白对内皮细胞株ECV304细胞释放前列环素、纤溶酶原激活物抑制剂的影响
18.
The Changes of the Plasiminogen Activitor Inhibitor-1(PAI-1) in Patients with Coronary Heart Desease and It s Relationship to Clinical Factors;
冠心病患者血浆纤溶酶原激活剂抑制因子（PAI-1）的变化及其相关因素的研究